Research study on phage-inspired growth decoupled recombinant protein production in Escherichia coli
- Juergen Mairhofer

- May 28, 2020
- 1 min read
Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have collaborated with researchers from Vienna’s University of Natural Resources and Life Sciences (BOKU) on an important study of bacteriophage Inspired Growth-Decoupled Recombinant Protein Production in Escherichia coli.
The research study was authored by four enGenes scientists, Patrick Stargardt, Lukas Feuchtenhofer, and Juergen Mairhofer in partnership with Monika Cserjan-Puschmann and Prof. Gerald Striedner from BOKU.
Decoupling synthesis from cell growth
The article, accepted for publication in the American Chemical Society (ACS) Synthetic Biology journal, presents a novel approach for improved recombinant protein production (RPP) using E. coli by decoupling recombinant protein synthesis from cell growth and outlines the capabilities of the enGenes-eXpress technology within a peer-reviewed format.
The authors show that cell division and host mRNA transcription can be successfully inhibited by co-expression of a bacteriophage-derived E. coli RNA polymerase (RNAP) inhibitor peptide and that genes over-transcribed by the orthogonal T7 RNAP can finally account for more than 55 per cent of cell dry mass (CDM).
For more information follow https://www.pharmaceutical-networking.com/engenes-bacteriophage-inspired-e-coli-rpp-research-study/



This is the kind of post I end up bookmarking and forwarding to a couple of people. I've found the same thing in practice, so it was reassuring to see it spelled out here. I touched on the same subject from a different perspective at blaze-swaps.com a little while back.
This came at a good time for me, and your perspective gave me a few things to reconsider. The emphasis on fundamentals over shortcuts is advice that ages well, in my experience. For more along these lines, feel free to check out ambientfinance.org whenever you have a moment.